Inventor
OOMEN RAYMOND P
CA50 patents
⚠️ This page may combine multiple inventors who share the name “OOMEN RAYMOND P”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
CONNAUGHT LAB
18 patentsUS6147057ANov 14, 2000
Analog of Haemophilus Hin47 with reduced protease activity
CONNAUGHT LAB17 citations93
US6114125ASep 5, 2000
Analog of Haemophilus Hin47 with reduced protease activity
CONNAUGHT LAB17 citations93
US6025342AFeb 15, 2000
Analog of Haemophilus Hin47 with reduced protease activity
CONNAUGHT LAB19 citations93
US5981503ANov 9, 1999
Analog of Haemophilus Hin47 with reduced protease activity
CONNAUGHT LAB19 citations93
US5939297AAug 17, 1999
Analog of haemophilus HIN47 with reduced protease activity
CONNAUGHT LAB20 citations93
US5935573AAug 10, 1999
Method of use of an analog of Haemophilus influenzae Hin47 with reduced protease activity
CONNAUGHT LAB19 citations93
US5869302AFeb 9, 1999
Analog of haemophilus hin47 with reduced protease activity
CONNAUGHT LAB21 citations93
US5656436AAug 12, 1997
Analog of Haemophilus Hin47 with reduced protease activity
CONNAUGHT LAB20 citations93
US5506139AApr 9, 1996
Analog of haemophilus Hin47 with reduced protease activity
CONNAUGHT LAB27 citations93
US6018022AJan 25, 2000
Modification of pertussis toxin
CONNAUGHT LAB16 citations92
US5977304ANov 2, 1999
Modification of pertussis toxin
CONNAUGHT LAB17 citations92
US5965385AOct 12, 1999
Modification of pertussis toxin
CONNAUGHT LAB20 citations92
US5856122AJan 5, 1999
Modification of pertussis toxin
CONNAUGHT LAB22 citations92
US5665353ASep 9, 1997
Composition containing an analog of haemophilus Hin47 with reduced protease activity
CONNAUGHT LAB17 citations82
US6168928B1Jan 2, 2001
Modification of pertussis toxin
CONNAUGHT LAB11 citations81
US6403101B1Jun 11, 2002
Chlamydia antigens and corresponding DNA fragments and uses thereof
CONNAUGHT LAB6 citations73
US6020182AFeb 1, 2000
Subunit respiratory syncytial virus vaccine preparation
CONNAUGHT LAB12 citations72
US6403102B1Jun 11, 2002
Chlamydia antigens and corresponding DNA fragments and uses thereof
CONNAUGHT LAB5 citations62
SANOFI PASTEUR LTD
17 patentsUS7081245B2Jul 25, 2006
Chlamydia antigens and corresponding DNA fragments and uses thereof
SANOFI PASTEUR LTD26 citations92
US7070792B2Jul 4, 2006
Chlamydia antigens and corresponding DNA fragments and uses thereof
SANOFI PASTEUR LTD25 citations92
US7019125B2Mar 28, 2006
Chlamydia antigens and corresponding DNA fragments and uses thereof
SANOFI PASTEUR LTD26 citations92
US7662391B2Feb 16, 2010
Chlamydia outer membrane protein (OMP) and vaccine uses of the protein
SANOFI PASTEUR LTD9 citations84
US7297341B1Nov 20, 2007
Chlamydia antigens and corresponding DNA fragments and uses thereof
SANOFI PASTEUR LTD9 citations74
US7183402B2Feb 27, 2007
Chlamydia antigens and corresponding DNA fragments and uses thereof
SANOFI PASTEUR LTD5 citations74
US7736873B2Jun 15, 2010
Chlamydia polypeptides and corresponding DNA fragments and uses thereof
SANOFI PASTEUR LTD1 citations63
US7658934B2Feb 9, 2010
Chlamydia antigens and protein vaccine
SANOFI PASTEUR LTD1 citations63
US7629327B2Dec 8, 2009
Chlamydia 60 Kda CRMP antigens and vaccine uses
SANOFI PASTEUR LTD1 citations63
US7595058B2Sep 29, 2009
Chlamydia antigens and vaccine uses of the protein
SANOFI PASTEUR LTD1 citations63
US7553493B2Jun 30, 2009
Chlamydia flagellar protein antigen
SANOFI PASTEUR LTD1 citations63
US7326545B2Feb 5, 2008
Chlamydia antigens and corresponding DNA fragments and uses thereof
SANOFI PASTEUR LTD1 citations63
US7314869B2Jan 1, 2008
Chlamydia antigens and corresponding DNA fragments and uses thereof
SANOFI PASTEUR LTD3 citations63
US7285276B2Oct 23, 2007
Chlamydia antigens and corresponding DNA fragments and uses thereof
SANOFI PASTEUR LTD4 citations63
US7166289B2Jan 23, 2007
Nucleic acid molecules encoding inclusion membrane protein C of Chlamydia
SANOFI PASTEUR LTD2 citations62
US7851213B2Dec 14, 2010
Tumor antigens BFA4 and BCY1 for prevention and / or treatment of cancer
SANOFI PASTEUR LTD3 citations60
US7850980B2Dec 14, 2010
Chlamydia OMP antigen
SANOFI PASTEUR LTD0 citations52
AVENTIS PASTEUR
10 patentsUS6808713B1Oct 26, 2004
Chlamydia antigens and corresponding DNA fragments and uses thereof
AVENTIS PASTEUR29 citations92
US6693087B1Feb 17, 2004
Nucleic acid molecules encoding POMP91A protein of Chlamydia
AVENTIS PASTEUR31 citations92
US6521745B1Feb 18, 2003
Nucleic acid molecules encoding inclusion membrane protein C of Chlamydia
AVENTIS PASTEUR30 citations92
US6686339B1Feb 3, 2004
Nucleic acid molecules encoding inclusion membrane protein C of Chlamydia
AVENTIS PASTEUR7 citations73
US6660275B2Dec 9, 2003
Chlamydia antigens and corresponding DNA fragments and uses thereof
AVENTIS PASTEUR6 citations73
US6642025B2Nov 4, 2003
Chlamydia antigens and corresponding DNA fragments and uses thereof
AVENTIS PASTEUR5 citations73
US6309649B1Oct 30, 2001
Subunit respiratory syncytial virus vaccine preparation
AVENTIS PASTEUR7 citations72
US6872814B2Mar 29, 2005
Chlamydia antigens and corresponding DNA fragments and uses thereof
AVENTIS PASTEUR3 citations62
US6649370B1Nov 18, 2003
Chlamydia antigens and corresponding DNA fragments and uses thereof
AVENTIS PASTEUR6 citations62
US7335370B2Feb 26, 2008
Chlamydia antigens and corresponding DNA fragments and uses thereof
AVENTIS PASTEUR0 citations52